Your browser doesn't support javascript.
loading
Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy.
Holliday, E B; Kuban, D A; Levy, L B; Bolukbasi, Y; Master, P; Choi, S; Nguyen, Q; McGuire, S E; Mahmood, U; Frank, S J; Hoffman, K E.
Afiliación
  • Holliday EB; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kuban DA; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Levy LB; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bolukbasi Y; American Hospital, Istanbul, Turkey.
  • Master P; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Choi S; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nguyen Q; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • McGuire SE; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mahmood U; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Frank SJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hoffman KE; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Prostate Cancer Prostatic Dis ; 20(4): 389-394, 2017 12.
Article en En | MEDLINE | ID: mdl-28462945
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antineoplásicos Hormonales / Antagonistas de Andrógenos Tipo de estudio: Prognostic_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Prostate Cancer Prostatic Dis Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antineoplásicos Hormonales / Antagonistas de Andrógenos Tipo de estudio: Prognostic_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Prostate Cancer Prostatic Dis Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos